Related Experiment Video
Updated: Jun 24, 2026

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage
Published on: August 30, 2020
Hydrocephalus after Subarachnoid Hemorrhage: Pathophysiology, Diagnosis, and Treatment
Sheng Chen1, Jinqi Luo1, Cesar Reis2
1Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China; Brain Research Institute, Zhejiang University, Hangzhou, China.
Insights
Hydrocephalus after subarachnoid hemorrhage involves inflammation and oxidative stress. Current treatments focus on surgery, while new therapies are in early development.
Area of Science:
- Neuroscience and Neurology
- Neurosurgery
- Molecular Biology
Background:
- Hydrocephalus (HCP) is a frequent complication following subarachnoid hemorrhage (SAH).
- Understanding the molecular mechanisms and therapeutic advancements for post-SAH HCP is crucial.
Purpose of the Study:
- To review current research on hydrocephalus following subarachnoid hemorrhage.
- To explore the molecular origins, diagnostic methods, and treatment strategies for HCP post-SAH.
Main Methods:
- Comprehensive literature review of advanced research on hydrocephalus after subarachnoid hemorrhage.
- Analysis of molecular pathways, diagnostic approaches, and surgical interventions.
Main Results:
- Key molecular contributors to HCP include inflammation, apoptosis, autophagy, and oxidative stress.
- Transforming growth factor, matrix metalloproteinases, and iron are implicated in fibrosis and blockage.
- Surgery remains the primary treatment, with various methods like lamina terminalis fenestration and shunting procedures.
Conclusions:
- Hydrocephalus post-SAH is a significant condition requiring further research into its development and improved patient prognosis.
- While surgical interventions are effective, they carry inherent risks, and pharmacological treatments are still in preclinical stages.
Abstract:
Hydrocephalus (HCP) is a common complication in patients with subarachnoid hemorrhage. In this review, we summarize the advanced research on HCP and discuss the understanding of the molecular originators of HCP and the development of diagnoses and remedies of HCP after SAH. It has been reported that inflammation, apoptosis, autophagy, and oxidative stress are the important causes of HCP, and well-known molecules including transforming growth factor, matrix metalloproteinases, and iron terminally lead to fibrosis and blockage of HCP. Potential medicines for HCP are still in preclinical status, and surgery is the most prevalent and efficient therapy, despite respective risks of different surgical methods, including lamina terminalis fenestration, ventricle-peritoneal shunting, and lumbar-peritoneal shunting. HCP remains an ailment that cannot be ignored and even with various solutions the medical community is still trying to understand and settle why and how it develops and accordingly improve the prognosis of these patients with HCP.
Related Concept Videos
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Brain Abscess l: Introduction
Increased Intracranial Pressure ll: Pathophysiology
Cerebral Edema l: Introduction
Cerebral Edema ll: Pathophysiology

